BMC Pulmonary Medicine

Table 2 Mean (+/-SD) BALF and serum levels of studied cytokines in the three groups of patients.

From: The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome

	Group A (n = 20)		Group B (n = 12)		Group C (n = 27)
Cytokines (pg/mL)	BALF	Serum	BALF	Serum	BALF	Serum
IL-4	260 ± 181	158 ± 68	284 ± 119	95 ± 35¹	242 ± 147	83 ± 68¹
IL-6	538 ± 432²	388 ± 324³	1135 ± 1382²	505 ± 217	318 ± 446	313 ± 373³
IL-6r	180 ± 52	30 ± 25	80 ± 37⁴	34 ± 26	73 ± 22⁴	39 ± 45
IL-8	480 ± 222	3525 ± 1523⁵	492 ± 165	3543 ± 2265⁵	467 ± 179	2553 ± 2824
IL-10	62 ± 24	117 ± 60	111 ± 98	177 ± 117	73 ± 50	118 ± 84

¹p < 0.0001 versus group A, ²p < 0.01 versus group C. ³p < 0.05 versus group B. ⁴p < 0.0001 versus group A. ⁵p < 0.0001 versus group C.

Back to article page

ISSN: 1471-2466

Contact us

Submission enquiries: bmcpulmonarymedicine@biomedcentral.com
General enquiries: ORSupport@springernature.com